A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice.

Penelope Koraka, Berend-Jan Bosch, Manon Cox, Rick Chubet, Geert van Amerongen, Karen Lövgren-Bengtsson, Byron E E Martina, Jouke Roose, Peter J M Rottier, Albert D M E Osterhaus

    Research output: Contribution to journalArticleAcademicpeer-review

    Abstract

    Rabies is a disease characterized by an invariably lethal encephalitis of viral origin that can be controlled by preventive vaccination programs of wildlife, domestic animals and humans in areas with a high risk of exposure. Currently available vaccines are expensive, cumbersome to produce and require intensive immunization and booster schemes to induce and maintain protective immunity. In the present study, we describe the development of candidate recombinant subunit rabies vaccines based on the glycoprotein G of the prototype rabies virus (RABV-G) expressed either as a monomer (RABV-mG) or in its native trimeric configuration (RABV-tG), with or without Matrix-M™ adjuvant. Immunogenicity and protective efficacy of the respective candidate vaccines were tested in outbred NIH Swiss albino mice. The RABV-tG candidate vaccine proved to be superior to the RABV-mG vaccine candidate both in terms of immunogenicity and efficacy. The relatively poor immunogenicity of the RABV-mG vaccine candidate was greatly improved by the addition of the adjuvant. A single, low dose of RABV-tG in combination with Matrix-M™ induced high levels of high avidity neutralizing antibodies and protected all mice against challenge with a lethal dose of RABV. Consequently RABV-tG used in combination with Matrix-M™ is a promising vaccine candidate that overcomes the limitations of currently used vaccines.
    Original languageEnglish
    Pages (from-to)4644-4650
    JournalVaccine
    Volume32
    Issue number36
    DOIs
    Publication statusPublished - 2014

    Keywords

    • Rabies
    • Vaccine
    • Glycoprotein G
    • Matrix-MTM

    Fingerprint

    Dive into the research topics of 'A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice.'. Together they form a unique fingerprint.

    Cite this